Announced Fri, 7 Aug · 10:34 IST
Blue Jet Healthcare Q1 FY27 earnings call transcript filed
Mgmt Guided Margin ImprovementMgmt Guided Margin PressureOrder Pipeline DisclosedMgmt Evaded Key QuestionInvestor Communications View source PDFExplain this filing
BLUEJET · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.7%1-day move
₹587.90
prior close
₹593.65
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1+0.1-0.0+0.1+0.7+0.4+0.0+1.0-0.3+2.9————
Up moveDown movePending
AI summary
Q1 FY27 revenue at INR293 crores, up 25% QoQ. EBITDA margin rose to 33.5% from 30.4%, though gross margin slipped 3% to 53% on raw material costs. PI/API segment led growth after customer destocking ended. Contrast media dipped due to INR30 crores goods in transit. FY27 capex guided at INR250 crores, Vizag project at INR1000 crores over 3 years. Tracking 20 RFPs with 4 chronic programs advancing.
Likely market impact
PI/API recovery and Vizag expansion support growth outlook; raw material costs and contrast media delays remain near-term margin risks.